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AIM
Investigate if modelling the insulin-like 
growth factor (IGF)-Axis as a gene-
network can identify gene-interactions  
predictive of the early onset of elevated 
systolic blood pressure (SBP) in 
developing children. 
RATIONALE
 Elevated BP is a symptom and a disease
Consistent, persistent elevated BP 
(140mmHg SBP/90mmHg DBP) = Clinical 
Hypertension
Established cardiovascular (CVD) risk-
factor
Is the leading cause of adult death and 
disability in the world through its 
predisposition to CVD events e.g. MI, 
stroke, obesity, type-II diabetes, 
metabolic syndrome



https://www.metalyse.com/myocardial_infarction/risk_factors.h  
High BP
Genetic Factors
https://www.metalyse.com/myocardial_infarction/risk_factors.h  
Why are we looking here?
Rather than here?
Hanson MA, Gluckman PD. Early developmental conditioning of later health and disease: physiology or pathophysiology? Physiol Rev. 2014 Oct;94(4):1027-76.
BP DATA
Raine (Western Australian Longitudinal 
Pregnancy and Birth Cohort)
Data from 2,279 individuals who had at 
least one SBP measure recorded at 5, 8, 
10, 12, 14 and 17 years of age
The most being recorded at age five 
(1,947 individuals) and the least at the 17 
year follow-up (1,249 individuals)
GENETIC DATA: IGF-Axis
IGF-Axis
Gene Number of SNPs Percentage of SNPs
IGF-1 15 9
IGF-1R 82 50
IGF-2 8 5
IGF-2R 38 23
IGFBP1 5 3
IGFBP2 4 2
IGFBP3 5 3
IGFBP4 3 2
IGFBP5 5 3
Total 165 100
THE MODEL
 Following Tsonaka et al, we used a two-stage 
mixed effects model to estimate a gene 
interaction network involving the nine genes of 
the IGF axis and model their association with 
the longitudinal SBP outcome
 Stage 1 generates gene-based random effects 
summarising the SNP effects within each gene
 Stage 2 uses the gene-specific random effects 
from stage 1 to model the gene-gene 
interactions against SBP
STAGE 1: Genetic Model
 Here we model the probability of carrying a 
particular SNP allele (the rare allele) as a 
function of fixed and random effects that 
represent genetic variations of the SNP 
genotypes at S loci studied
 A logistic model is used to specify the 
probability to carry at least one rare allele 
(dominant model) or two rare alleles 
(recessive model) as a Bernouilli trial
 This model will return the empirical Bays (EB) 
estimates of the random effects
STAGE 1: Genetic Model
𝐥𝐥𝐥𝐥𝐥𝐥
𝝅𝝅𝒊𝒊𝒊𝒊
𝟏𝟏−𝝅𝝅𝒊𝒊𝒊𝒊
= 𝑿𝑿𝑿 𝒊𝒊𝒊𝒊𝛽𝛽 + 𝒃𝒃𝒊𝒊 + 𝒃𝒃𝒊𝒊𝒊𝒊 + 𝒃𝒃𝒊𝒊𝒊𝒊𝒊𝒊
 𝛽𝛽′ is a vector of regression coefficients on specific covariates 𝑋𝑋𝑖𝑖𝑖𝑖𝑿𝑠𝑠 that could 
account for specific SNP characteristics, if any is included.
 𝑏𝑏𝑖𝑖𝑖~ 𝑁𝑁(0,𝜎𝜎2) is a random intercept effect for each individual 𝑖𝑖. 
 𝑏𝑏𝑖𝑖𝑖𝑖~ 𝑁𝑁(0,𝜎𝜎𝑔𝑔2) is a random effect for each SNP j within individual 𝑖𝑖. It is 
assumed independent for each individual 𝑖𝑖 and independent of 𝑏𝑏𝑖𝑖𝑖, but the  
bij’ s are correlated across genes.
 𝑏𝑏𝑖𝑖𝑖𝑖𝑔𝑔~ 𝑁𝑁(0,𝜎𝜎𝑔𝑔2) is a random effect for each gene g and SNP j within individual 𝑖𝑖. 
It is assumed independent for each individual 𝑖𝑖 and independent of 𝑏𝑏𝑖𝑖 𝑎𝑎𝑎𝑎𝑎𝑎 𝑏𝑏𝑖𝑖𝑖𝑖.
 For each individual and each gene, an empirical bayes estimate can be 
obtained from the gene-based lme by adding the three random effects:
�𝑒𝑒𝑏𝑏𝑖𝑖𝑔𝑔 = �𝑏𝑏𝑖𝑖 + �𝑏𝑏𝑖𝑖𝑖𝑖 + �𝑏𝑏𝑖𝑖𝑖𝑖𝑔𝑔
Let 𝜋𝜋𝑖𝑖𝑖𝑖 be the probability for an individual 𝑖𝑖 (𝑖𝑖 = 1,… ,𝑎𝑎) to carry a variant in 
the SNP 𝑗𝑗 = 1,… , 165 across the particular gene it belongs to, given we 
have 9 genes 𝑔𝑔 = (1,… , 9). The gene-based lme can be written as: 
STAGE 2: Longitudinal Model
 Here gene-specific estimates are tested using the EB 
estimates �𝒆𝒆𝒃𝒃𝒊𝒊𝒊𝒊
∗ from the first stage as covariates in 
the mixed-effects model for longitudinal SBP
 To model the longitudinal outcome, a linear mixed-
effects model with random intercepts and random 
slopes was used
 A model fitting procedure was implemented to 
identify the optimal set of variables that should be 
included in this longitudinal gene-network model
 Age, Sex and BMI
STAGE 2: Longitudinal Model
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∗ ∗ (𝑺𝑺𝑩𝑩𝑩𝑩𝒊𝒊𝒊𝒊+(𝑨𝑨𝒊𝒊𝒆𝒆𝒊𝒊𝒊𝒊∗ 𝑺𝑺𝒆𝒆𝑺𝑺𝒊𝒊))𝜼𝜼 + 𝒖𝒖𝒊𝒊 + 𝜺𝜺𝒊𝒊𝒊𝒊
 𝑡𝑡 (= 1,… , 5) represents the number of follow-up visits at approximately (1) 5 years, (2), 8 years, (3) 
10 years, (4) 14 years and (5) 17 years
 𝑋𝑋𝑖𝑖𝑖𝑖 = Design matrix for the fixed effect covariates which include; BMI, sex and age
 𝐴𝐴𝑔𝑔𝑒𝑒𝑖𝑖𝑖𝑖 = 5-14 years vs. 15+ years. In brief, these timeframes were chosen to reflect dramatic changes 
in developmental growth. Further justification surrounding these ‘epochs’ can be found in chapters 
six and seven. 
 𝑆𝑆𝑒𝑒𝑆𝑆𝑖𝑖 = Males or Females 
 𝐵𝐵𝐵𝐵𝐵𝐵𝑖𝑖 = per unit (kg/m2) increase in year of age
 𝛽𝛽= Vector of regression coefficients on the fixed effects variables BMI, sex and age
 �𝑒𝑒𝑏𝑏𝑖𝑖𝑔𝑔
∗ = gene-specific empirical Bayes random effects estimated from stage 1
 𝛾𝛾 = vector of regression coefficients on the gene-gene specific effects. It quantifies the effect of the 
pathway components on the longitudinal SBP outcome.
 𝜂𝜂 = regression coefficients that capture the variation of gene by gene interactions with age (as a 
discrete variable) and sex on  𝑆𝑆𝐵𝐵𝑆𝑆. It quantifies the age-specific effect of the pathway on the 
longitudinal SBP outcome.
 𝑢𝑢i~𝑁𝑁(0, 𝜎𝜎2) = random intercept for each individual 𝑖𝑖
 𝜖𝜖𝑖𝑖𝑖𝑖 ~ 𝑁𝑁 (0,𝜎𝜎𝜖𝜖2) = Within individual error term with variance 𝜎𝜎𝜖𝜖2
 The 𝑢𝑢𝑖𝑖
′ 𝑠𝑠 are assumed correlated and independent from the 𝜀𝜀𝑖𝑖𝑿𝑠𝑠. 
Results
Comparing extreme 
gene-network 
profiles
Figure legends
 Only presenting Bonferroni-corrected p-values < 0.0001
 Effects are presented separately by sex
Females
Males
 Increases to SBP are denoted by dashed lines 
 Reductions to SBP are denoted by solid lines
 Thickness of the line indicates the level of significance 
(i.e. thicker line = more statistically significant           
than thinner lines         )
 Colour of the line indicates the effect size (i.e. the darker 
the line, the larger the effect          compared to lighter 
coloured lines = smaller the effect size         )
Extreme top 5% (< 15 years)
Extreme top 5% (15+ years)
CONCLUSIONS
 Children aged over 15 years had a much more active 
gene-network influencing SBP compared to children 
aged < 15 years
 For children aged less than 15 years only males were 
statistically significantly associated with elevated SBP
 IGF1-IGFBP4
 IGF1R-IGFBP1-IGFBP3
 For females aged 15 years and over, increases to 
extreme SBP was observed between 
 IGF2 and IGFBP2 and IGFBP4
 IGFBP2-IGFBP5 (and IGF1R-IGFBP5)
 For males aged 15 years and over, increases to extreme 
SBP was observed between 
 IGF2 and IGFBP2 and IGFBP5
 IGF1R-IGFBP4
Females Males
Overlapping effects between males and females 
for increasing elevated SBP was observed for the 
gene-gene interactions of IGF2-IGFBP2-IGFBP5
MEANING AND RELEVANCE
 The results attained are reasonable and 
align logically with current literature
 Polymorphisms within IGF2 have already 
been shown to influence regulation of blood 
pressure in obese children
 We found that this gene-network is 
modified with age; this in itself may be due 
to a number of reasons including diet, 
hormones and developmental growth over 
time, particularly post-puberty
FUTURE
 Further investigation using this method and 
larger datasets would be ideal to validate our 
findings and improve accuracy surrounding the 
estimates produced from these models and 
further improve the power to detect complex 
interactions
 Through characterizing the association 
between multiple genes and disease outcomes 
we will offer new insight into disease aetiology 
whilst providing tools for making individualized 
treatment decisions
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